Irodalom
1. SEVE P., RENAUDIER P., SASCO A. J., ET AL.: Hepatitis C virus infection and B-cell non-Hodgkin’s
lymphoma: a cross-sectional study in Lyon, France. Eur J Gastroenterol Hepatol 2004; 16:
1361-1365.
2. ISAACSON P.G., MING-QING DU: Gastrointestinal lymphoma: where morphology meets molecular
biology. J Pathol 2005; 205: 255-274.
3. MARTINELLI G., LASZLO D., FERREI A.J.M., ET AL.: Clinical activity of rituximab in gastric marginal
zone non-Hodgkin’s lymphoma resistant to or not eligible for anti-helicobacter pylori therapy.
J Clin Oncol 2005; 23: 1979-1983.
4. NAKAMURA SHIGEO, NAKAMURA SHOTARO, MATSUMOTO T., ET AL.: Overexpression of caspase recruitment
domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary
gastric B-cell lymphoma. Cancer 2005; 104: 1885-1893.
5. WÖHRER S., STREUBEL B., BARTSCH R., ET AL.: Monoclonal immunoglobulin production is a frequent
event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res 2004;
10: 7179-7181.
6. STREUBEL B., HONGTAO YE, MING-QING DU, ET AL.: Translocation t(11;18)(q21;q21) is not predictive
of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. Oncology
2004; 66: 476-480.
7. FISCHBACH W.: Mucosa-associated lymphoid tissue lymphoma: lessons from Germany. In:
Gastroenterology Yesterday-Today-Tomorrow: A Review and Preview. Ed: Adler G., Blum A.L.,
Blum H.E., Leuschner U., Manns M.P., Mössner J., Sartor R.B., Schölmerich J. Springer, 2005;
76-83.
8. HATA S., PIETSCH J., SHANKAR S.: Intestinal complications in children undergoing chemotherapy
for mediastinal non-Hodgkin’s lymphoma. Pediatric Hematology and Oncology 2004; 21: 707-
710.
9. AYADI-KADDOUR A., CHELLY-ENNEIFER I., GOUTALLIER-BEN FADHEL C., ET AL.: Intestinal T cell lymphoma
in coeliac disease. A case report. Tunis Med. 2005; 83(5): 311-314.
10. TAJI S., NOMURA K., MATSUMOTO Y., ET AL.: Trisomy 3 may predict a poor response of gastric
MALT lymphoma to Helicobacter pylori eradication therapy. World J Gastroenterol 2005;
11(1): 89-93.
11. LEE M.Y., TSOU M-H., TAN T.D., ET AL.: Clinicopathological analysis of T-cell lymphoma in Taiwan
according to WHO classifi cation: high incidence of enteropathytype intestinal T-cell lymphoma.
Eur J Haematol 2005; 75: 221-226.
12. TSANG R.W., GOSPODAROWICZ M.K.: Radiation therapy for localized low-grade non-Hodgkin’s
lymphomas. Hematol Oncol 2005; 23: 10-17.
13. FISCHBACH W., CHAN A.O., WONG B.C.: Helicobacter pylori and gastric malignancy. Helicobacter
2005; 10 Suppl 1: 34-39.
14. KUO S.H., CHEN L.T., CHEN C.L., ET AL.: Expression of CD86 and increased infi ltration of NK
cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric
MALT lymphoma. World J Gastroenterol 2005; 11(28): 4357-4362.
15. CHEUNG D.Y., HAN J.Y., PARK S.H., ET AL.: Gastric marginal zone B-cell lymphoma of MALT-type
mimicking early gastric cancer. Gastrointestinal Endoscopy 2005; 4: 615-616.
16. LÉVY M., COPIE-BERGMAN C., GAMEIRO C., ET AL.: Prognostic value of translocation t(11;18) in tumoral
response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral
chemotherapy. J Clin Oncol 2005; 23: 5061-5066.
17. BERTONI F., ZUCCA E.: State-of-the-art therapeutics: marginal-zone lymphoma. J Clin Oncol 2005;
23:6415-6420.
18. FARINHA P., GASCOYNE R.D.: Molecular pathogenesis of mucosa-associated lymphoid tissue
lymphoma. J Clin Oncol 2005; 23: 6370-6378.
19. BILSEL Y., BALIK E., YAMANER S., ET AL.: Clinical and therapeutic considerations of rectal lymphoma:
a case report and literature review. World J Gastroenterol 2005; 11(3): 460-461.
20. ROMAGUERA J., HAGEMEISTER F.B.: Lymphoma of the colon. Curr Opin Gastroenterol 2005; 21(1):
80-84.
21. GRETHLEIN S.: Mucosa-associated lymphoid tissue. www.emedicine.com
